The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

A stretch of viral DNA in the mouse genome gives cells in early-stage embryos the potential to become almost any cell type in ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

An international team including researchers from Nvidia and Microsoft has used AI on a biological trove of more than a ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

The AI model "Eden" is intended to generate new gene therapies for cancer and rare diseases, as well as active ingredients ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer ...

Canada is wrestling with how gene-editing should translate to voluntary genetically modified food labels, or whether it even ...